Fig. 6
From: Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
Reduction of lipid accumulation in TSD NSCs after treatment with HPβCD. a Nile Red staining of TSD NSC HT134A and HT151A after 48 h treatment with HPβCD ranging from 0 to 500 uM. b Normalized percent Nile Red IxA of TSD NSCs after treated with HPβCD (n = 40; SEM). Nile Red IxA of HPβCD treated TSD NSCs were normalized to untreated TSD NSCs IxA as 100% and WT NSCs IxA as 0%. IxA, integrated cell intensity